EQUIPP® Refresh Notice: August 11, 2023
The latest dataset was made available in EQUIPP® as of August 11, 2023. This dataset now includes 6-month performance information based off of prescription drug claims from January 1, 2023 through June 30, 2023.
YTD Date Range: January 1, 2023 - June 30, 2023
Things to Know:
Webinar Recordings - Please visit our New Resource Materials Section for our most recently recorded webinars.
Influenza Performance Update:
The Influenza Vaccination measures is now available in EQUIPP® and will be tracked through the 2022-2023 flu season, with a final measurement date ending March 31, 2023. Note: This reporting period for the 2022-2023 Flu season has concluded.
NEW! Enhanced Services Data Update: Beginning August 1st, pharmacies with available opportunities in the Controlling Blood Pressure and A1C Enhanced Services programs will begin seeing patient data in EQUIPP. These programs will provide an incentive payment to participating pharmacies for each electronic blood pressure reading completed or A1C test captured for available patient opportunities. Additional information including a detailed program description with instructional information will be provided as linked documents in EQUIPP.
NEW! Tile Reset Button
In the performance dashboard, there is now a designated button to reset measure tiles back to alphabetical format.
NEW! Quality Improvement Programs (QIP) Table Filtering Capability: The Quality Improvement Table on the measure performance page now has the ability to filter by all columns: program name, number of patients, performance score, gap, program goal, and percentile. Filtering by gap is the latest improvement to this table.
Latest Feature: We’ve heard your feedback for a list of all patients and now the feature is here! The All Patients View is a comprehensive view of all patients attributed to your pharmacy in the EQUIPP platform. For navigation tips, please visit our EQUIPP Resources.
NEW! Updated EQUIPP Videos
PQS has updated EQUIPP educational videos to match our current platform. Our first three videos can be accessed in this YouTube playlist.